Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To Methotrexate

ClinicalTrials.gov ID: NCT02996500

Public ClinicalTrials.gov record NCT02996500. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 8:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12 WEEK RANDOMIZED, DOUBLE-BLIND, DOUBLE DUMMY, PARALLEL GROUP, ACTIVE AND PLACEBO-CONTROLLED, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY PROFILE OF PF-06650833 IN SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE

Study identification

NCT ID
NCT02996500
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
269 participants

Conditions and interventions

Interventions

  • PF-06650833 Drug
  • Placebo Drug
  • Tofacitinib Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 9, 2016
Primary completion
Aug 14, 2018
Completion
Aug 14, 2018
Last update posted
Feb 26, 2020

2016 – 2018

United States locations

U.S. sites
15
U.S. states
8
U.S. cities
12
Facility City State ZIP Site status
Clinical and Translational Research Center of Alabama, PC Tuscaloosa Alabama 35406
Dory Hardy, PharmD Tucson Arizona 85723
Southern Arizona VA Health care System Tucson Arizona 85723
Robert W. Levin, MD,PA Clearwater Florida 33765
Millennium Research Ormond Beach Florida 32174
Arthritis & Rheumatic Care Center South Miami Florida 33143
Qps-Mra, Llc South Miami Florida 33143
Medical Associates of North Georgia Canton Georgia 30115
Graves Gilbert Clinic Bowling Green Kentucky 42101
Arthritis and Diabetes Clinic, Inc. Monroe Louisiana 71203
Ramesh C Gupta, M.D. Memphis Tennessee 38119
Accurate Clinical Management, LLC Baytown Texas 77521
Accurate Clinical Management, LLC Houston Texas 77004
Accurate Clinical Management, LLC Houston Texas 77084
DM Clinical Research Tomball Texas 77375

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 88 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02996500, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 26, 2020 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02996500 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →